Anti-Human CD40 Recombinant Antibody (Dacetuzumab) (CAT#: TAB-152)

Descripción: Recombinant monoclonal antibody to CD40. Dacetuzumab (also known as SGN-40 or huS2C6) is a humanized monoclonal antibody being developed for the treatment of CD40-positive cancers like non-Hodgkin's lymphoma and hematological malignancies.

Fecha de Publicación: 20-02-24